340B Program success depends on the quality of self-auditing
Healthcare organizations participating in the 340B Drug Pricing Program should self-audit of their compliance with the program to ensure its ongoing success and effectiveness.
Provider responses to prospective compromise on surprise billing range from concerns to opposition
Congressional healthcare committees are urging leaders to include a “compromise” on surprise medical bills in year-end legislation, but providers are worried about it.
HHS starts distribution of $24 billion more in COVID grants but rejects one-third of applicants
More than 70,000 providers will share in the latest round of Provider Relief Fund grants, which total $24.5 billion.
Financial Sustainability Report: November 2020
The November 2020 Financial Sustainability Report, sponsored by Kaufman Hall, explores the long-term implications for hospitals and health systems of the deferral of elective procedures at the start of the COVID-19 pandemic, and it provides insights into healthcare organizations’ need for consumer-focused strategies. Other topics include 340B compliance and revenue cycle redesign after COVID-19.
Medicare phases out the inpatient-only list, backs off further 340B payment cuts
The final rule for the CY21 Medicare Outpatient Prospective Payment System will phase out the inpatient-only list but won’t implement steeper 340B cuts.
Stark, Anti-Kickback changes draw praise from providers
Final rules modifying enforcement of the Stark Law and the Anti-Kickback Statute aim to remove barriers to participation in value-based payment models.
News briefs: December-January 2020-21: Recent trends shaping healthcare finance
Read about the key factors that have shaped healthcare finance policy and practice.
Financial Sustainability Report: April 2020
The April issue of the Financial Sustainability Report, sponsored by Kaufman Hall, offers insights that can help healthcare finance leaders guide their organizations through the COVID-19 crisis and develop long-term solutions in preparation for a new healthcare landscape in the aftermath.
CMS’s latest guidance for healthcare organizations on the new coronavirus
The HFMA editorial team will continuously post the latest announcements from the Centers for Medicare & Medicaid Services (CMS) related to the COVID-19 outbreak.
California v. Texas: What’s next?
HFMA's Chad Mulvany says we won’t know the outcome of the case until sometime in the first half of next year.